A Phase I Study of Oral Fluoropyrimidine Capecitabine (Xeloda Roche) Combined With Intravenous Cisplatin in Patients With Advanced Cancer of the Digestive System.
Phase of Trial: Phase I
Latest Information Update: 04 Apr 2011
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin
- Indications Advanced breast cancer; Cancer; Gastrointestinal cancer; Head and neck cancer; Lung cancer
- Focus Adverse reactions
- 25 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Aug 2005 New trial record.